Asarina Pharma AB (publ) (ASAP.ST)

SEK 0.03

(-31.03%)

Market Cap (In SEK)

633.95 Thousand

Revenue (In SEK)

-

Net Income (In SEK)

-12.82 Million

Avg. Volume

282.13 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.028-1.315
PE
-
EPS
-
Beta Value
0.166
ISIN
SE0011641794
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Peter Nordkild M.D.
Employee Count
-
Website
https://www.asarinapharma.com
Ipo Date
2018-09-24
Details
Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.